{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:19:05Z","timestamp":1786119545598,"version":"build-2736575974"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1097\/wnf.0b013e3181e1612e","type":"journal-article","created":{"date-parts":[[2010,7,26]],"date-time":"2010-07-26T21:29:58Z","timestamp":1280179798000},"page":"215-216","source":"Crossref","is-referenced-by-count":0,"title":["Two Cases of Panic Disorder Responsive to Low-Dose Sertraline"],"prefix":"10.1097","volume":"33","author":[{"given":"Herbert","family":"Orenstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"suppl 2","key":"R1-13-20210203","first-page":"1S","article-title":"Clinical practice guidelines-management of anxiety disorders.","volume":"51","author":"Swinson","year":"2006","journal-title":"Can J Psychiatry"},{"key":"R2-13-20210203","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1056\/NEJMcp052466","article-title":"Panic disorder.","volume":"354","author":"Katon","year":"2006","journal-title":"N Engl J Med"},{"key":"R3-13-20210203","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1001\/archpsyc.55.11.1010","article-title":"Sertraline in the treatment of panic disorder.","volume":"55","author":"Pollack","year":"1998","journal-title":"Arch Gen Psychiatry"},{"key":"R4-13-20210203","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1192\/bjp.173.1.54","article-title":"Sertraline in the treatment of panic disorder: a multi-site, double-blind, placebo-controlled, fixed-dose investigation.","volume":"173","author":"Londborg","year":"1998","journal-title":"Br J Psychiatry"},{"key":"R5-13-20210203","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1176\/ajp.155.9.1189","article-title":"Sertraline in the treatment of panic disorder: a double-blind multicenter trial.","volume":"155","author":"Pohl","year":"1998","journal-title":"Am J Psychiatry"},{"key":"R6-13-20210203","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00004850-200015060-00004","article-title":"The efficacy of sertraline in panic disorder: combined results from two fixed-dose studies.","volume":"15","author":"Sheikh","year":"2000","journal-title":"Int Clin Psychopharmacol"},{"key":"R7-13-20210203","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4088\/JCP.09l05016blu","article-title":"Dosing by side effect threshold: two cases of panic disorder responsive to low dose venlafaxine.","volume":"71","author":"Orenstein","year":"2010","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"R8-13-20210203","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating.","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br J Med Psychol"},{"key":"R9-13-20210203","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(06)69418-X","article-title":"Panic disorder.","volume":"368","author":"Roy-Byrne","year":"2006","journal-title":"Lancet"},{"key":"R10-13-20210203","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1176\/ajp.147.4.532b","article-title":"Overcoming hypersensitivity to fluoxetine in a patient with panic disorder.","volume":"147","author":"Giesecke","year":"1990","journal-title":"Am J Psychiatry"},{"key":"R11-13-20210203","doi-asserted-by":"crossref","first-page":"224","DOI":"10.4088\/PCC.v03n0507a","article-title":"Dosing of selective serotonin reuptake inhibitors.","volume":"3","author":"Chung","year":"2001","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"R12-13-20210203","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/01.jcp.0000096248.95165.ac","article-title":"Sertraline in panic disorder: initial treatment versus switch strategy.","volume":"23","author":"Mavissakalian","year":"2003","journal-title":"J Clin Psychopharmacol"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/WNF.0b013e3181e1612e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:32:46Z","timestamp":1786041166000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002826-201007000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e3181e1612e","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}